Performance analysis of Inhibikase Therapeutics (IKT)
Annual Return
Over the past 3 years, IKT has had an average annual return of -6.59%, underperforming the benchmark SPY, which returned +19.62% annual.
Over the past 5 years, IKT has had an average annual return of -31.62%, underperforming the benchmark SPY, which returned +12.73% annual.
Since Dec 23, 2020, IKT has had an average annual return of -44.49%, underperforming the benchmark SPY, which returned +15.12% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +8.70% | -36.93% | +155.61% | -57.62% | -65.99% | -78.69% | -30.30% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -26.67% | +36.36% | -17.97% | +12.37% | -7.23% | +15.93% | +9.65% | +8.70% | |||||
| 2025 | -30.16% | +1.31% | -4.65% | +2.98% | -11.05% | -2.96% | -18.90% | +13.91% | -9.90% | -9.52% | +3.64% | +34.77% | -36.93% |
| 2024 | +137.38% | -28.35% | -0% | -32.14% | +25.51% | -34.19% | +16.18% | -0.42% | -7.20% | +94.52% | +15.49% | +11.18% | +155.61% |
| 2023 | +41.19% | +4.63% | -10.99% | -15.06% | +23.23% | -12.52% | -30.26% | -20.28% | -30.77% | -36.32% | +6.04% | +35.44% | -57.62% |
| 2022 | -4.78% | -24.26% | +39.59% | -27.02% | -15.22% | -18.92% | +14.40% | +12.94% | -5.16% | -15.13% | -21.67% | -17.35% | -65.99% |
| 2021 | -3.49% | +0.61% | -10.30% | -12.98% | +2.29% | -47.67% | -18.92% | +4.40% | -19.84% | +4.74% | +0.50% | -26.49% | -78.69% |
| 2020 | -30.30% | -30.30% |
Drawdown analysis of Inhibikase Therapeutics (IKT)
The maximum drawdown for the IKT was -98.64%, occurring on Oct 9, 2023. This drawdown has not yet recovered.
The current IKT drawdown is -96.25%.
Since Dec 23, 2020 IKT has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.64% | Dec 23, 2020 | 701 | Oct 9, 2023 | Ongoing | Ongoing | Ongoing |